Surrozen Inc (SRZN) Live Share Price, Invest From India

Surrozen Inc Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$28.84
Day's Price Range
$31.46
$30.77
6.27%
Downside
2.24%
Upside
52 Week's Low
52 Week's High
$5.90
52-Week Price Range
$35.00
$30.77
80.83%
Downside
13.75%
Upside

Surrozen Inc share price movements today

Previous Close: $29.28
Open: $29.30
Volume: 253.5K
Day's Low - High: $28.84 - $31.46
52 Week Low - High: $5.90 - $35.00

Surrozen Inc Historical Returns

1 Month Return: + 3.83 %
3 Month Return: + 17.85 %
1 Year Return: + 266 %
3 Year Return: + 242.7 %
5 Year Return: 0 %

Surrozen Inc Stock Fundamentals & Key Indicators

Check Surrozen Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$336.2M

EPS (TTM)

-3.7

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-42.7M

Revenue (TTM)

7.5M

Profit Margin

0.00%

Return On Equity TTM

-62.80%

Surrozen Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Surrozen Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Surrozen Inc	BUY	$336.2M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Stock Returns calculator for Surrozen Inc Stock including INR - Dollar returns

The Surrozen Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Surrozen Inc investment value today

Current value as on today

₹4,33,260

Returns

₹3,33,260

(+333.26%)

Returns from Surrozen Inc Stock

₹2,84,625 (+284.63%)

Dollar Impact

₹48,635 (+48.64%)

Analyst Recommendation on Surrozen Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Surrozen Inc. Average target price of $42.5

Surrozen Inc Share Price Target

Get share price movements and forecasts by analysts on Surrozen Inc.

What analysts predicted

27.6%UPSIDE

Target Price

$42.5

Current Price

$30.77

Analyzed by

8 Analysts

Target

$42.50

Surrozen Inc target price $42.5, a slight upside of 27.6% compared to current price of $30.77. According to 8 analysts rating.

Surrozen Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	4	-	10	0	0	0	0	0	5
Gross Profit	-	0	0	10	0	0	0	0	0	4
Operating Income	-9	-9	-9	1	-8	-9	-9	-10	-12	-10
EBITDA	-	-8	-8	1	-8	-9	-8	-71	-12	-10
Interest Expense	-	0	-	-	1	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-8	-8	-25	-1	-28	-26	39	-71	-183	-127
Income Tax Expense	-	0	-	-	0	-	-	-	-	-
Net Income	-8	-8	-25	-1	-28	-26	39	-71	-183	-127
Net Profit Margin	0.00%	-212.98%	0.00%	-14.34%	-4280.76%	-2743.64%	4043.34%	-7288.20%	-34689.20%	-2550.10%

Surrozen Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	12	12	10	3
Gross Profit	-2	-3	12	-27	10	2
Operating Income	-32	-54	-44	-45	-25	-42
EBITDA	-31	-52	-42	-41	-24	-41
Interest Expense	0	2	1	-	-	-
Depreciation	1	2	1	1	1	0
Income Before Tax	-32	-54	-36	-43	-63	-242
Income Tax Expense	0	-2	-8	2	-63	-
Net Income	-32	-52	-27	-43	-63	-242
Net Profit Margin	0.00%	0.00%	-221.35%	-344.34%	-596.56%	-6960.77%

Surrozen Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-8	-25	-1	-28	-26	39	-71	-183	-127
Operating Cash Flow	-8	-5	-6	3	-9	-6	-9	-5	-12
Investing Cash Flow	0	-	-	0	0	0	0	0	0
Financing Cash Flow	0	16	0	0	76	-5	0	13	30
Change in Cash	-8	10	-6	3	67	-11	-9	7	17

Surrozen Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-32	-54	-36	-43	-63	-242
Operating Cash Flow	-29	-48	-44	-40	-17	-30
Investing Cash Flow	-15	-77	38	51	0	0
Financing Cash Flow	50	124	-2	0	16	85
Change in Cash	5	-1	-8	11	-1	54

Global Institutional Holdings in Surrozen Inc

Funds	Holdings
StemPoint Capital LP	5.4%
Schonfeld Strategic Advisors LLC	0.87%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)	0.64%
Longwood Capital Partners LLC	1.55%
Stonepine Capital Management Llc	0.99%

See all

Insights on Surrozen Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SRZN has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, SRZN has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 7 days, SRZN stock has moved down by -14.2%

About Surrozen Inc

Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Organisation	Surrozen Inc
Headquarters	171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Mr. Craig C. Parker M.B.A.
E-voting on shares	Click here to vote

Key Management of Surrozen Inc

Name	Title
Mr. Michael Lauw M.S.W.	Senior Vice President of Development Operations
Mr. Charles Williams	COO & Corporate Secretary
Dr. Yang Li Ph.D.	Executive Vice President of Research
Dr. K. Christopher Garcia Ph.D.	Co-Founder & Member of Scientific Advisory Board
Mr. Andrew Maleki	Chief Financial Officer
Dr. Daniel L. Chao M.D., Ph.D.	VP & Head of Clinical Development
Esther Jhun	Controller
Mr. Craig C. Parker M.B.A.	CEO, President & Director
Dr. Roeland Nusse Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Calvin Kuo M.D., Ph.D.	Co-Founder & Member of Scientific Advisor

FAQs

What is Surrozen Inc share price today?

Surrozen Inc share price today is $30.77 as on May 13, 2026 at 1:29 am IST at the close of the market. Surrozen Inc share today touched a day high of $31.46 and a low of $28.84.

What is the 52 week high and 52 week low for Surrozen Inc share?

Surrozen Inc share touched a 52 week high of $35 on May 7, 2026 and a 52 week low of $5.9 on May 16, 2025. Surrozen Inc stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $30.77,which is 12.09% down from its 52 week high and 421.53% up from its 52 week low.

What is Surrozen Inc's market capitalisation today?

Surrozen Inc market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in Surrozen Inc Stock (SRZN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Surrozen Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Surrozen Inc Shares that will get you 0.0487 shares as per Surrozen Inc share price of $30.77 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Surrozen Inc Stock (SRZN) from India?

Indian investors can start investing in Surrozen Inc (SRZN) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Surrozen Inc stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:42 am IST). Based on Surrozen Inc share’s latest price of $30.77 as on May 13, 2026 at 1:29 am IST, you will get 0.3250 shares of Surrozen Inc. Learn more about fractional shares .